HDAC-IN-36 is an orally active HDAC (histone deacetylase) inhibitor with an IC50 value of 11.68 nM for HDAC6. HDAC-IN-36 induces apoptosis, autophagy and inhibits migration. HDAC-IN-36 exhibits antitumor and antimetastatic effects and can be used to study breast cancer. HDAC-IN-36 exhibits antitumor and antimetastatic effects and can be used to study breast cancer.

HDAC11:>1000 nM, HDAC7:>1000 nM, HDAC3:79.17 nM, HDAC10:13.24 nM, HDAC6:11.68 nM, HDAC2:97.32 nM, HDAC8:378.2 nM, HDAC4:>1000 nM, HDAC1:86.93 nM, HDAC9:>1000 nM, HDAC5:>1000 nM